Model.
Discover.
Predict.
Transforming the treatment of cardiac fibrosis through innovative drug discovery.
Transforming Therapeutic Development
We advance preclinical drug development by integrating induced pluripotent stem cells with multiple read-outs including biosensor technologies, harnessing translatable solutions for drug discovery. Model, Discover, and Predict—work together to model diseases, uncover therapeutic targets, and forecast drug efficacy in human-relevant systems.
Our state-of-the-art laboratory is located in the Technopark Montréal, fostering innovation within a vibrant biotech community.
We screen our own compounds for our drug discovery program and serve partners in their disease modelling and drug discovery needs. We can collaborate for imaging-based drug discovery in many different cellular venues.
Revolutionizing Disease Modeling with Induced Pluripotent Stem Cells
Learn More
Uncovering Therapeutic Targets Through Cellular Signaling
Learn More
Predicting Therapeutic Outcomes with Human-Relevant Models
Learn MoreMeet Our Team
.jpg)
Our dedicated scientists and professionals are at the forefront of preclinical drug development and are committed to finding treatments for fibrotic diseases such as cardiac fibrosis.